The Biological AI Company

Building the Operating System for Intelligent Biological Systems

We pioneer the integration of artificial intelligence and biology to create programmable intelligent organisms that solve humanity's greatest challenges.

Bio-OS Platform

The world's first self-learning AI-biology operating system

Intelligent Organisms

Programmable biological systems with autonomous learning capabilities

Industry Solutions

Transforming healthcare, energy, materials, and agriculture

Global Impact

Solving humanity's greatest challenges through biological intelligence

About Lucidix

Redefining the future by merging artificial intelligence with biological systems

Our Mission

Lucidix is pioneering the world's first Biological AI platform—a revolutionary system where artificial intelligence and living organisms merge to create programmable, self-learning biological systems. We're building the operating system for intelligent life itself.

Our technology enables the creation of organisms that can diagnose diseases, produce clean energy, manufacture advanced materials, and adapt to environmental changes—all with the precision of software and the complexity of life.

Founder's Vision

"We stand at the threshold of a new era—the Biological AI Revolution. Just as computers transformed the 20th century, intelligent biological systems will define the 21st. At Lucidix, we're not just building technology; we're architecting the future of life itself."

- Afsaneh Taheri Kal-Koshvandi, Founder & CEO

Innovation Timeline

2025 Initial Bio-AI platform patents filed - Foundation of Biological AI

2025 18+ patents establishing comprehensive IP moat in Biological AI

2026 Bio-OS MVP launch - First self-learning biological systems

2027 First commercial applications in healthcare and energy

Founder & CEO

Dr. Afsaneh Taheri Kal-Koshvandi - Pioneer of Biological AI

Architect of the Biological AI Revolution

Dr. Afsaneh Taheri Kal-Koshvandi is the visionary founder and CEO of Lucidix Inc., pioneering the field of Biological AI—the integration of artificial intelligence with living biological systems. Her groundbreaking work has established the foundation for creating programmable, self-learning organisms.

With extensive expertise in synthetic biology, AI systems, and therapeutic development, Dr. Taheri has invented the core technologies that enable biological systems to process information, learn from their environment, and execute complex programs—essentially creating biological computers.

Under her leadership, Lucidix has rapidly expanded its intellectual property portfolio with 18+ foundational patents and is positioned to transform multiple industries through its revolutionary Bio-OS platform.

18+

Foundational Patents

1st

Biological AI Platform

$500B+

Market Potential

Industries Transformed

Download Full CV LinkedIn Profile

Technology Platform

Our revolutionary Bio-OS platform for intelligent biological systems

Bio-OS Core

The world's first operating system for biological intelligence—enabling programming, execution, and learning in living systems with unprecedented precision.

LucID Intelligence

Self-learning biological AI that enables organisms to adapt, optimize, and evolve their functions based on environmental inputs and desired outcomes.

NeuralSync Networks

Distributed biological computing networks that enable coordinated intelligence across multiple organisms and systems.

EvoLogic Engine

Advanced evolutionary algorithms that accelerate the development of optimized biological solutions through guided selection and improvement.

BioCompute Fabric

The underlying infrastructure that enables biological systems to process information and execute complex programs at molecular scale.

Adaptive Interface

Human-Bio AI interface that allows seamless programming and interaction with intelligent biological systems across multiple industries.

Investment Opportunity

Join us in building the future of Biological AI

Founding the $500B Biological AI Industry

Lucidix is positioned to become the defining company of the Biological AI revolution—the next frontier after digital computing. We're building the foundational platform that will enable programming intelligence into biological systems.

Request Investment Deck

Market Leadership

First-mover in the $500B+ Biological AI market with 18+ foundational patents creating an unbreachable IP moat.

Platform Advantage

Bio-OS platform serves multiple industries—healthcare, energy, materials, agriculture—creating exponential revenue opportunities.

Proven Technology

Core technologies validated through peer-reviewed research and protected by comprehensive patent portfolio.

Funding Roadmap

Seed Round - $30M (0-12 months)

$150M Valuation

Focus: Team building, Bio-OS MVP development, patent expansion, first industry partnerships

Series A - $80M (12-24 months)

$800M Valuation

Focus: Platform scaling, clinical validation, market expansion, strategic acquisitions

Series B - $300M (24-36 months)

$3B Valuation

Focus: Global expansion, IPO preparation, industry dominance, platform ecosystem development

Confidential Investor Information

For accredited investors and strategic partners interested in our seed round, please contact us directly for the complete investment deck and executive summary.

Email: afsanehtaheri6396@gmail.com

Research & Publications

Groundbreaking research in Biological AI and intelligent systems

Taheri Kal-Koshvandi, A. (2025).

Bio-OS: A Framework for Programmable Biological Intelligence. Nature Biotechnology (Submitted).

Introducing the world's first operating system for creating self-learning biological systems with AI capabilities.

Kal-Koshvandi, A. T. (2025).

LucID: A Self-Activating Bioluminescent Biotin Ligase for Light-Free Proximity Labeling in Deep Tissues. bioRxiv, 2025-06.

https://doi.org/10.1101/2025.06.10.658826

Kal-Koshvandi, A. T. (2025).

Quintuple BRET Platform for Light-Free, Compartment-Resolved Proximity Proteomics in Neurons.

Advanced platform for neural circuit mapping and biological computing infrastructure.

Patent Portfolio

18+ foundational patents protecting our Biological AI platform (2025 provisional filings)

Bio-OS Core Platform

Biological Operating System Architecture
Self-Learning Biological AI Algorithms
BioCompute Processing Framework
Distributed Biological Intelligence

Healthcare Intelligence

Autonomous Diagnostic Systems
Self-Optimizing Therapeutics
Adaptive Drug Delivery
Personalized Medicine AI

Industrial Applications

Intelligent Energy Production
Self-Assembling Materials
Adaptive Agricultural Systems
Environmental Remediation AI

Computing Infrastructure

Biological Neural Networks
Molecular Scale Processing
Bio-Data Storage Systems
Evolutionary Optimization

Development Pipeline

Strategic roadmap to Biological AI leadership

Platform Development (2025–2026)

Bio-OS MVP completion

Core technology validation

First industry applications

Market Expansion (2027–2028)

Healthcare applications launch

Energy & materials pilots

Global partnership network

Industry Leadership (2029+)

Multiple market dominance

Platform ecosystem maturity

Global impact at scale

Join Our Mission

We're seeking visionary investors and strategic partners to accelerate the Biological AI revolution.

Contact Us

Get in touch to explore partnership and investment opportunities

Connect With Us

afsanehtaheri6396@gmail.com
Delaware, USA
+98 930 852 0957

For Investors

Interested in our $30M seed round? Contact us directly for the complete investment deck and executive summary.

Send Us a Message

Thank you for your message! We'll get back to you within 24 hours.

There was an error sending your message. Please email us directly at afsanehtaheri6396@gmail.com